 "JB Chemicals surges 12% as board mulls share buyback proposal")
JB Chemicals & Pharmaceuticals has rallied 12% to Rs 338 on the BSE in intra-day trade after the company announced that its board will meet on August 31, 2018, to consider a share buyback proposal.
“The meeting of the board of directors of the Company is scheduled on August 31, 2018 at which the board will consider the proposal for Buy-back of fully paid-up equity shares by the Company and other matters incidental thereto,” JB Chemicals said in a statement.
The primary objective of a share buyback programme is to arrest the fall in the value of a stock by reducing the supply of the stock, which essentially pushes up the share price through a better P/E multiple. The other objective is to improve earnings per share (since the same dividend amount is now distributed among fewer shares).
Thus far in the calendar year 2018, JB Chemicals had underperformed the market by falling 9% as compared to 12% rise in the S&P BSE Sensex till Tuesday.
At 03:18 PM; the stock was trading 8% higher at Rs 328 on the BSE, as compared to 0.19% rise in the S&P BSE Sensex. The trading volumes on the counter jumped more than 10-fold with a combined 1.23 million equity shares changed hands on the BSE and NSE so far.
“The meeting of the board of directors of the Company is scheduled on August 31, 2018 at which the board will consider the proposal for Buy-back of fully paid-up equity shares by the Company and other matters incidental thereto,” JB Chemicals said in a statement.
The primary objective of a share buyback programme is to arrest the fall in the value of a stock by reducing the supply of the stock, which essentially pushes up the share price through a better P/E multiple. The other objective is to improve earnings per share (since the same dividend amount is now distributed among fewer shares).
Thus far in the calendar year 2018, JB Chemicals had underperformed the market by falling 9% as compared to 12% rise in the S&P BSE Sensex till Tuesday.
At 03:18 PM; the stock was trading 8% higher at Rs 328 on the BSE, as compared to 0.19% rise in the S&P BSE Sensex. The trading volumes on the counter jumped more than 10-fold with a combined 1.23 million equity shares changed hands on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%